{"id":"W2137667786","doi":"10.1158/1535-7163.mct-05-0504","title":"Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts","year":2006,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Erlotinib; MAPK/ERK pathway; Ribosomal protein s6; Pharmacology; Epidermal growth factor receptor; Cancer research; Kinase; Epidermal growth factor; Phosphorylation; EGFR inhibitors; Medicine; Vascular endothelial growth factor; Erlotinib Hydrochloride; Chemistry; Biology; Protein kinase A; Internal medicine; Receptor; Biochemistry; Protein phosphorylation; VEGF receptors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001227361,0.0002531109,0.0002731766,0.0001102786,0.00004517111,0.00002074234,0.0002610112,0.0001421453,0.00004553805],"category_scores_gemma":[0.000004515664,0.0002407034,0.0001175304,0.0003131359,0.0001350514,0.000005977269,0.00005588198,0.0001998048,0.000001678671],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007292641,"about_ca_system_score_gemma":0.0001905665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003944376,"about_ca_topic_score_gemma":0.0007371692,"domain_scores_codex":[0.9985207,0.0001043593,0.0003762372,0.0004000753,0.0002498013,0.0003488525],"domain_scores_gemma":[0.9991833,0.0000211819,0.0001678963,0.0004146866,0.0001605249,0.00005238535],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005717687,0.0001735857,0.04233285,0.00003739538,0.0001251706,0.00001916879,0.00008004998,0.006374164,0.9493828,0.0001181177,0.00005836117,0.0007265775],"study_design_scores_gemma":[0.001932594,0.0005779266,0.008902966,0.00008426667,0.00008723215,0.00001100187,0.0000619253,0.0002914822,0.9801264,0.0001306774,0.007452527,0.0003410285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911937,0.002979525,0.004437942,0.0002544423,0.0002144631,0.0003005907,0.00003110978,0.00001868034,0.0005696178],"genre_scores_gemma":[0.9977612,0.00004883134,0.001091095,0.0005770408,0.000171431,0.0000914636,0.00006936285,0.00006587547,0.0001236831],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03342988,"threshold_uncertainty_score":0.9815599,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01582704422381388,"score_gpt":0.2724241610232969,"score_spread":0.256597116799483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}